N/A N=10 Randomized Single-blind Other

Youth Mayo Clinic Anxiety Coach Pilot Study

Anxiety

Bottom Line

View on ClinicalTrials.gov: NCT02205177 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Aug 2019

Primary outcome: Primary: Mean Change From Baseline in Pediatric Anxiety Rating Scale (PARS) at Treatment Completion — 11; -1 score on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Mayo Clinic Anxiety Coach (Device)
Age: Pediatric · 7+ yrs
Sex: All
Sponsor: Stephen Whiteside
Primary completion: Mar 2017

Outcome Measures

Outcome	Result	p-value
PRIMARY Mean Change From Baseline in Pediatric Anxiety Rating Scale (PARS) at Treatment Completion	11; -1	—
SECONDARY Number of Participants Who Completed the Subject Safety and Treatment Adherence Interview	5; 0	—

Summary

This research study aims to test the feasibility and effectiveness of using the Mayo Clinic Anxiety Coach smartphone app as an addition to traditional therapy for the treatment of anxiety disorders in youth, particularly those youth who may have limited access to mental health treatment in the traditional clinical setting.

Eligibility Criteria

Inclusion Criteria

Age 7 to 17
Primary diagnosis of:
social phobia,
separation anxiety disorder,
panic disorder with and without agoraphobia,
specific phobia, or
obsessive compulsive disorder
A parent or other primary care giver available to participate with the child in all assessment and treatment activities
Estimated average intelligence
English speaking

Exclusion Criteria

History of and/or current diagnosis of:
psychosis,
autism,
bipolar disorder,
mental retardation,
oppositional defiant disorder,
PTSD,
selective mutism, or
major depressive disorder
Current suicidality or recent suicidal behavior
Parent to be involved in study who is unable to adequately participate due to intellectual or psychiatric difficulties
Starting or changing the dosage of a psychiatric medication in the last two months

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02205177). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.